The Priority Review

Tag

Actinium Pharmaceuticals

1 story

  1. Policy

    Actinium Pharmaceuticals names Sean Maenpaa senior vice president of business development

    The appointment takes effect on October 12, 2026, and the new executive will lead partnering, licensing and strategic transactions across Actinium's targeted radiotherapy pipeline. He brings more than two decades of oncology business development experience, including senior roles at Bayer, Clovis Oncology, Telix Pharmaceuticals and BWXT Medical.